: Medication abortion access hangs in balance as appeals court hears mifepristone case 

FDA drug approval process at issue in case challenging widely used abortion pill

Previous post Earnings Results: Take-Two stock soars as outlook suggests ‘Grand Theft Auto VI’ is a little more than a year away
Next post Earnings Results: Cisco earnings beat, but revenue guidance is reduced and the stock is struggling for direction